|
1
|
Vogiatzi P, Vindigni C, Roviello F,
Renieri A and Giordano A: Deciphering the underlying genetic and
epigenetic events leading to gastric carcinogenesis. J Cell
Physiol. 211:287–295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mackenzie M, Spithoff K and Jonker D:
Systemic therapy for advanced gastric cancer: a clinical practice
guideline. Curr Oncol. 18:e202–e209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Connolly RM, Nguyen NK and Sukumar S:
Molecular pathways: current role and future directions of the
retinoic acid pathway in cancer prevention and treatment. Clin
Cancer Res. 19:1651–1659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garattini E, Gianni M and Terao M:
Retinoids as differentiating agents in oncology: a network of
interactions with intracellular pathways as the basis for rational
therapeutic combinations. Curr Pharm Des. 13:1375–1400. 2007.
View Article : Google Scholar
|
|
5
|
Gui SY, Chen FH, Zhou Q and Wang Y:
Effects of novel all-trans retinoic acid retinamide derivatives on
the proliferation and apoptosis of human lung adenocarcinoma cell
line A549 cells. Yakugaku Zasshi. 131:1465–1472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang B, Yan Y, Zhou J, Zhou Q, Gui S and
Wang Y: A novel all-trans retinoid acid derivatives inhibits the
migration of breast cancer cell lines MDA-MB-231 via myosin light
chain kinase involving p38-MAPK pathway. Biomed Pharmacother.
67:357–362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang G, Wang G, Wang S, Li Q, Ouyang G
and Peng X: Applying proteomic methodologies to analyze the effect
of hexamethylene bisacetamide (HMBA) on proliferation and
differentiation of human gastric carcinoma BGC-823 cells. Int J
Biochem Cell Biol. 36:1613–1623. 2004. View Article : Google Scholar
|
|
8
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Somlyo AP and Somlyo AV: Signal
transduction by G-proteins, rho-kinase and protein phosphatase to
smooth muscle and nonmuscle myosin II. J Physiol. 522:177–185.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Totsukawa G, Wu Y, Sasaki Y, et al:
Distinct roles of MLCK and ROCK in the regulation of membrane
protrusions and focal adhesion dynamics during cell migration of
fibroblasts. J Cell Biol. 164:427–439. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ito M, Nakano T, Erdodi F and Hartshorne
DJ: Myosin phosphatase: structure, regulation and function. Mol
Cell Biochem. 259:197–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong CC, Wong CM, Ko FC, et al: Deleted in
liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in
hepatocellular carcinoma. PLoS One. 3:e27792008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Soprano DR, Qin P and Soprano KJ: Retinoic
acid receptors and cancers. Annu Rev Nutr. 24:201–221. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Q, Chen ZM and Su WJ: Anticancer effect
of retinoic acid via AP-1 activity repression is mediated by
retinoic acid receptor α and β in gastric cancer cells. Int J
Biochem Cell Biol. 34:1102–1114. 2002.PubMed/NCBI
|
|
15
|
Fang Y, Zhou X, Lin M, et al: The
ubiquitin-proteasome pathway plays essential roles in ATRA-induced
leukemia cells G0/G1 phase arrest and
transition into granulocytic differentiation. Cancer Biol Ther.
10:1157–1167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nowak G, Griffin JM and Schnellmann RG:
Hypoxia and proliferation are primarily responsible for induction
of lactate dehydrogenase activity in cultured cells. J Toxicol
Environ Health. 49:439–452. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fishman WH: Recent developments in
alkaline phosphatase research. Clin Chem. 38:24841992.PubMed/NCBI
|
|
18
|
Lu J, Zhang F, Yuan Y, Ding C, Zhang L and
Li Q: All-trans retinoic acid upregulates the expression of
p53 via Axin and inhibits the proliferation of glioma cells. Oncol
Rep. 29:2269–2274. 2013.
|
|
19
|
Zhou X, Liu Y, You J, Zhang H, Zhang X and
Ye L: Myosin light-chain kinase contributes to the proliferation
and migration of breast cancer cells through cross-talk with
activated ERK1/2. Cancer Lett. 270:312–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen L, Su L, Li J, et al: Hypermethylated
FAM5C and MYLK in serum as diagnosis and pre-warning
markers for gastric cancer. Dis Markers. 32:195–202. 2012.
|
|
21
|
Minamiya Y, Nakagawa T, Saito H, et al:
Increased expression of myosin light chain kinase mRNA is related
to metastasis in non-small cell lung cancer. Tumour Biol.
26:153–157. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lochhead PA, Wickman G, Mezna M and Olson
MF: Activating ROCK1 somatic mutations in human cancer. Oncogene.
29:2591–2598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N, Bi F, Pan Y, et al: Reversal of the
malignant phenotype of gastric cancer cells by inhibition of RhoA
expression and activity. Clin Cancer Res. 10:6239–6247. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuoka T, Yashiro M, Kato Y, Shinto O,
Kashiwagi S and Hirakawa K: RhoA/ROCK signaling mediates plasticity
of scirrhous gastric carcinoma motility. Clin Exp Metastasis.
28:627–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakagawa O, Fujisawa K, Ishizaki T, Saito
Y, Nakao K and Narumiya S: ROCK-I and ROCK-II, two isoforms of
Rho-associated coiled-coil forming protein serine/threonine kinase
in mice. FEBS Lett. 392:189–193. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vicente-Manzanares M, Ma X, Adelstein RS
and Horwitz AR: Non-muscle myosin II takes centre stage in cell
adhesion and migration. Nat Rev Mol Cell Biol. 10:778–790. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Runkle EA and Mu D: Tight junction
proteins: from barrier to tumorigenesis. Cancer Lett. 337:41–48.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanada Y, Oue N, Mitani Y, Yoshida K,
Nakayama H and Yasui W: Down-regulation of the claudin-18 gene,
identified through serial analysis of gene expression data
analysis, in gastric cancer with an intestinal phenotype. J Pathol.
208:633–642. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iravani O, Tay BW, Chua PJ, Yip GW and Bay
BH: Claudins and gastric carcinogenesis. Exp Biol Med. 238:344–349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oshima T, Shan J, Okugawa T, et al:
Down-regulation of claudin-18 is associated with the proliferative
and invasive potential of gastric cancer at the invasive front.
PLoS One. 8:e747572013. View Article : Google Scholar : PubMed/NCBI
|
